---
figid: PMC4121837__pnas.1406136111fig06
figtitle: Proposed model for 18-5p–mediated inhibition of viral reactivation through
  the MAPK signal transduction pathway
organisms:
- Homo sapiens
- NA
pmcid: PMC4121837
filename: pnas.1406136111fig06.jpg
figlink: /pmc/articles/PMC4121837/figure/fig06/
number: F6
caption: Proposed model for 18-5p–mediated inhibition of viral reactivation through
  the MAPK signal transduction pathway. Briefly, TPA triggers the PKC signaling pathway,
  and BCR stimulation activates the PI3K, PLC, Ras, and Rac1 pathways. Both pathways
  are mediated through MAP3K2 and activate downstream effector transcription factors
  that can activate the BZLF1 promoter (Zp), followed by BZLF1 protein expression
  and induction of the lytic cycle gene cascade. BART 18-5p represses MAP3K2 via binding
  to its 3′UTR, and thereby inhibits viral reactivation.
papertitle: EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo
  by inhibiting viral replication in B cells.
reftext: Jin Qiu, et al. Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):11157-11162.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9834578
figid_alias: PMC4121837__F6
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4121837__F6
ndex: 3822a87d-deba-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4121837__pnas.1406136111fig06.html
  '@type': Dataset
  description: Proposed model for 18-5p–mediated inhibition of viral reactivation
    through the MAPK signal transduction pathway. Briefly, TPA triggers the PKC signaling
    pathway, and BCR stimulation activates the PI3K, PLC, Ras, and Rac1 pathways.
    Both pathways are mediated through MAP3K2 and activate downstream effector transcription
    factors that can activate the BZLF1 promoter (Zp), followed by BZLF1 protein expression
    and induction of the lytic cycle gene cascade. BART 18-5p represses MAP3K2 via
    binding to its 3′UTR, and thereby inhibits viral reactivation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCR
  - RN7SL263P
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - KRAS
  - HRAS
  - NRAS
  - RAC1
  - RNASE1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - HADHA
  - PLAT
  - MAP3K2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K3
  - MAP2K4
  - MAP2K5
  - MAP2K6
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
